A Novel Approach to Extensive Clarithromycin-Resistant Mycobacterium avium Complex Pulmonary Disease. 2022

Takeo Togo, and Jun Atsumi, and Miyako Hiramatsu, and Kiyomi Shimoda, and Kozo Morimoto, and Yuji Shiraishi
Section of Chest Surgery, Fukujuji Hospital, Kiyose, Tokyo, Japan.

A 48-year-old woman with extensive clarithromycin-resistant Mycobacterium avium complex pulmonary disease (MAC-PD) was successfully treated by left lower lobectomy and lingulectomy following combination treatment of intravenous/inhaled amikacin plus bronchial occlusion by Endobronchial Watanabe Spigots (EWSs). A left pneumonectomy was initially indicated for removing all the lesions, but the procedure would have been barely tolerated by the patient. However, her preoperative combination treatment sufficiently reduced the lesions requiring resection to allow surgical preservation of the left upper division. This novel approach might be promising for patients with Mycobacterium avium complex lung disease whose pulmonary reserve will not allow an extensive parenchymal resection.

UI MeSH Term Description Entries
D008171 Lung Diseases Pathological processes involving any part of the LUNG. Pulmonary Diseases,Disease, Pulmonary,Diseases, Pulmonary,Pulmonary Disease,Disease, Lung,Diseases, Lung,Lung Disease
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D015269 Mycobacterium avium Complex A complex that includes several strains of M. avium. M. intracellulare is not easily distinguished from M. avium and therefore is included in the complex. These organisms are most frequently found in pulmonary secretions from persons with a tuberculous-like mycobacteriosis. Strains of this complex have also been associated with childhood lymphadenitis and AIDS; M. avium alone causes tuberculosis in a variety of birds and other animals, including pigs. Battey Bacillus,MAIC,Mycobacterium avium-intracellulare,Mycobacterium avium-intracellulare Complex,Mycobacterium intracellulare,Nocardia intracellularis
D015270 Mycobacterium avium-intracellulare Infection A nontuberculous infection when occurring in humans. It is characterized by pulmonary disease, lymphadenitis in children, and systemic disease in AIDS patients. Mycobacterium avium-intracellulare infection of birds and swine results in tuberculosis. Mycobacterium intracellulare Infection,Infection, Mycobacterium avium-intracellulare,Infection, Mycobacterium intracellulare,Mycobacterium avium intracellulare Infection,Infection, Mycobacterium avium intracellulare,Infections, Mycobacterium avium-intracellulare,Infections, Mycobacterium intracellulare,Mycobacterium avium-intracellulare Infections,Mycobacterium intracellulare Infections
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017291 Clarithromycin A semisynthetic macrolide antibiotic derived from ERYTHROMYCIN that is active against a variety of microorganisms. It can inhibit PROTEIN SYNTHESIS in BACTERIA by reversibly binding to the 50S ribosomal subunits. This inhibits the translocation of aminoacyl transfer-RNA and prevents peptide chain elongation. 6-O-Methylerythromycin,A-56268,Biaxin,TE-031,A 56268,A56268,TE 031,TE031

Related Publications

Takeo Togo, and Jun Atsumi, and Miyako Hiramatsu, and Kiyomi Shimoda, and Kozo Morimoto, and Yuji Shiraishi
August 2020, Respiratory medicine,
Takeo Togo, and Jun Atsumi, and Miyako Hiramatsu, and Kiyomi Shimoda, and Kozo Morimoto, and Yuji Shiraishi
July 2020, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy,
Takeo Togo, and Jun Atsumi, and Miyako Hiramatsu, and Kiyomi Shimoda, and Kozo Morimoto, and Yuji Shiraishi
September 1999, American journal of respiratory and critical care medicine,
Takeo Togo, and Jun Atsumi, and Miyako Hiramatsu, and Kiyomi Shimoda, and Kozo Morimoto, and Yuji Shiraishi
May 2014, Kekkaku : [Tuberculosis],
Takeo Togo, and Jun Atsumi, and Miyako Hiramatsu, and Kiyomi Shimoda, and Kozo Morimoto, and Yuji Shiraishi
January 2016, BMC infectious diseases,
Takeo Togo, and Jun Atsumi, and Miyako Hiramatsu, and Kiyomi Shimoda, and Kozo Morimoto, and Yuji Shiraishi
June 2023, Internal medicine (Tokyo, Japan),
Takeo Togo, and Jun Atsumi, and Miyako Hiramatsu, and Kiyomi Shimoda, and Kozo Morimoto, and Yuji Shiraishi
November 1993, Antimicrobial agents and chemotherapy,
Takeo Togo, and Jun Atsumi, and Miyako Hiramatsu, and Kiyomi Shimoda, and Kozo Morimoto, and Yuji Shiraishi
March 1994, Antimicrobial agents and chemotherapy,
Takeo Togo, and Jun Atsumi, and Miyako Hiramatsu, and Kiyomi Shimoda, and Kozo Morimoto, and Yuji Shiraishi
January 2014, Annals of the American Thoracic Society,
Takeo Togo, and Jun Atsumi, and Miyako Hiramatsu, and Kiyomi Shimoda, and Kozo Morimoto, and Yuji Shiraishi
February 1996, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease,
Copied contents to your clipboard!